A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of RS-79070 when used as induction therapy in patients
with newly diagnosed peripheral retinitis. To assess the effects of induction and maintenance
level dosing of RS-79070 on CMV viral load, estimated by plasma CMV PCR. To assess the
pharmacokinetics of ganciclovir following administration of RS-79070 in the target
population.